Landon, Boland et al. investigate the clinical and molecular impact of a combination of epigenetic modulation and immune checkpoint inhibition in platinum-resistant ovarian cancer. Serial transcriptomic analyses reveal reshaping of the tumor microenvironment toward a more inflammatory state that may enhance immunotherapy response.
- Blair V. Landon
- Julia L. Boland
- John A. Glaspy
